TMC Life Sciences Bhd (XKLS:0101) EBIT : RM75.1 Mil (TTM As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is TMC Life Sciences Bhd EBIT?

TMC Life Sciences Bhd's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was RM15.1 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was RM75.1 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. TMC Life Sciences Bhd's annualized ROC % for the quarter that ended in Mar. 2024 was 4.65%. TMC Life Sciences Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 8.39%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. TMC Life Sciences Bhd's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 6.38%.

TMC Life Sciences Bhd EBIT Historical Data

The historical data trend for TMC Life Sciences Bhd's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TMC Life Sciences Bhd EBIT Chart

TMC Life Sciences Bhd Annual Data

Trend

May13

May14

May15

May16

Aug17

Aug18

Aug19

Jun21

Jun22

Jun23

EBIT

Get a 7-Day Free Trial

33.19

38.24

28.11

34.28

50.30

TMC Life Sciences Bhd Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial															14.30	15.06	22.72	22.21	15.06

Competitive Comparison of TMC Life Sciences Bhd's EBIT

For the Medical Care Facilities subindustry, TMC Life Sciences Bhd's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TMC Life Sciences Bhd's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TMC Life Sciences Bhd's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where TMC Life Sciences Bhd's EV-to-EBIT falls into.

TMC Life Sciences Bhd EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was RM75.1 Mil.

TMC Life Sciences Bhd (XKLS:0101) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

TMC Life Sciences Bhd's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	54.66 * ( 1 - 20.04% )	/	( (936.184	+	944.139)	/ 2 )
=	43.706136	/	940.1615
=	4.65 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1191.303	-	79.207	-	( 190.337	-	max(0, 96.978	-	272.89	+	190.337	))
=	936.184

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1195.919	-	75.65	-	( 192.481	-	max(0, 97.452	-	273.582	+	192.481	))
=	944.139

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

TMC Life Sciences Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	60.256	/	( ( (711.302 + max(3.26, 0))	+	(715.753 + max(5.336, 0)) )	/	2 )
=	60.256	/	( ( 714.562	+	721.089 )	/	2 )
=	60.256	/	717.8255
=	8.39 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(59.03	+	12.835	+	10.688)	-	(79.207	+	0	+	0.085999999999999)
=	3.26

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(58.584	+	11.722	+	10.795)	-	(75.65	+	0	+	0.11499999999999)
=	5.336

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

TMC Life Sciences Bhd's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	75.062	/	1175.664
	=	6.38 %

TMC Life Sciences Bhd EBIT Related Terms

Thank you for viewing the detailed overview of TMC Life Sciences Bhd's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

TMC Life Sciences Bhd (XKLS:0101) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TMC Life Sciences Bhd (XKLS:0101) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, PJU 5, Jalan Teknologi, Level 11, Taman Sains, Kota Damansara, Petaling Jaya, SGR, MYS, 47810

Website

https://www.tmclife.com

TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.

TMC Life Sciences Bhd (XKLS:0101) Headlines

No Headlines